SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Orchard Therapeutics Announces Clinical Data Presentations at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation Aug. 29-Sept. 1

BOSTONandLONDON, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics(NASDAQ:ORTX), a global gene therapy leader, today announced presentations at the upcoming 46th Annual Meeting of the European Society for Blood and

Benzinga · 08/24/2020 11:08

BOSTONandLONDON, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics(NASDAQ:ORTX), a global gene therapy leader, today announced presentations at the upcoming 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), taking place virtually from August 29 - September 1, 2020. New interim data from OTL-203, an investigational gene therapy for the treatment of mucopolysaccharidosis type I (MPS-I), will be shared as part of an invited oral presentation titled ‘Gene Therapy in Leucodystrophies and Other Metabolic Disorders'.
 

The presentations are listed below and the full preliminary program is available online at the EBMT Annual Meeting website. Presentations will be available to registered attendees for virtual viewing throughout the duration of the live meeting and content will be accessible online following the close of the meeting.